AbCellera Biologics Inc. (ABCL)

AbCellera Biologics Statistics

Total Valuation

ABCL has a market cap or net worth of $610.87 million. The enterprise value is $59.88 million.

Market Cap	610.87M
Enterprise Value	59.88M

Important Dates

The last earnings date was Thursday, May 8, 2025, after market close.

Earnings Date	May 8, 2025
Ex-Dividend Date	n/a

Share Statistics

ABCL has 297.99 million shares outstanding. The number of shares has increased by 1.78% in one year.

Current Share Class	297.99M
Shares Outstanding	297.99M
Shares Change (YoY)	+1.78%
Shares Change (QoQ)	+0.74%
Owned by Insiders (%)	23.01%
Owned by Institutions (%)	33.94%
Float	201.90M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	25.83
Forward PS	17.93
PB Ratio	0.59
P/TBV Ratio	0.64
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	2.59
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.15, with a Debt / Equity ratio of 0.06.

Current Ratio	10.15
Quick Ratio	8.56
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -15.59% and return on invested capital (ROIC) is -15.86%.

Return on Equity (ROE)	-15.59%
Return on Assets (ROA)	-12.94%
Return on Invested Capital (ROIC)	-15.86%
Return on Capital Employed (ROCE)	-22.90%
Revenue Per Employee	$38,782
Profits Per Employee	-$281,658
Employee Count	596
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

Income Tax	-42.76M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -47.12% in the last 52 weeks. The beta is 0.46, so ABCL's price volatility has been lower than the market average.

Beta (5Y)	0.46
52-Week Price Change	-47.12%
50-Day Moving Average	2.31
200-Day Moving Average	2.70
Relative Strength Index (RSI)	36.13
Average Volume (20 Days)	4,633,264

Short Selling Information

The latest short interest is 23.01 million, so 7.72% of the outstanding shares have been sold short.

Short Interest	23.01M
Short Previous Month	23.78M
Short % of Shares Out	7.72%
Short % of Float	11.40%
Short Ratio (days to cover)	5.48

Income Statement

In the last 12 months, ABCL had revenue of $23.11 million and -$167.87 million in losses. Loss per share was -$0.57.

Revenue	23.11M
Gross Profit	-147.35M
Operating Income	-290.53M
Pretax Income	-178.81M
Net Income	-167.87M
EBITDA	-231.20M
EBIT	-290.53M
Loss Per Share	-$0.57

Balance Sheet

The company has $605.27 million in cash and $63.21 million in debt, giving a net cash position of $542.06 million or $1.82 per share.

Cash & Cash Equivalents	605.27M
Total Debt	63.21M
Net Cash	542.06M
Net Cash Per Share	$1.82
Equity (Book Value)	1.02B
Book Value Per Share	3.44
Working Capital	689.58M

Cash Flow

In the last 12 months, operating cash flow was -$78.40 million and capital expenditures -$64.89 million, giving a free cash flow of -$143.29 million.

Operating Cash Flow	-78.40M
Capital Expenditures	-64.89M
Free Cash Flow	-143.29M
FCF Per Share	-$0.48

Margins

Gross Margin	n/a
Operating Margin	-1,256.95%
Pretax Margin	-911.27%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ABCL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.78%
Shareholder Yield	n/a
Earnings Yield	-27.89%
FCF Yield	-23.81%

Analyst Forecast

The average price target for ABCL is $7.50, which is 265.85% higher than the current price. The consensus rating is "Buy".

Price Target	$7.50
Price Target Difference	265.85%
Analyst Consensus	Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	20.92%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ABCL has an Altman Z-Score of 1.67 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.67
Piotroski F-Score	2